PRME Stock-Based Compensation
Prime Medicine Inc · Stock-Based Compensation
PRME Stock-Based Compensation
Latest reported$26.77Mperiod ending
PRME TTM Stock-Based Comp (-$122.00K → $26.77M)
TTM stock-based compensation
High-resolution chart · PNG
PRME stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 26,771,000 | |
| 28,231,000 | |
| 29,268,000 | |
| 30,694,000 | |
| 24,774,000 | |
| 26,540,000 | |
| 26,068,000 | |
| 24,556,000 | |
| 21,946,000 | |
| 17,438,000 | |
| 13,910,000 | |
| 12,055,000 | |
| 9,255,000 | |
| 7,017,000 | |
| 6,459,000 | |
| 4,992,000 | |
| 3,914,000 | |
| 2,569,000 | |
| 1,446,000 | |
| 61,000 | |
| -122,000 |